Dudediligence.

Century Therapeutics, Inc

IPSCNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$791,000Sep ’24$4.2MDec ’24$109.2MMar ’25$0.00Dec ’25
Net income, by quarter
−$31.2MSep ’24−$36.1MDec ’24$76.6MMar ’25−$32.5MJun ’25−$34.4MSep ’25−$19.2MDec ’25−$21.6MMar ’26−$34.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$5.2M$2.2M$6.6M$109.2M
Operating income−$94.9M−$133.8M−$146.5M−$138.1M−$17.3M
Net income−$95.8M−$130.9M−$136.7M−$126.6M−$9.6M
Operating cash flow−$89.0M$14.1M−$88.3M−$110.1M−$103.9M
Free cash flow−$134.0M−$16.6M−$102.1M−$110.3M−$104.7M
Cash$56.4M$84.3M$47.3M$58.4M$61.9M
Debt$9.9M$10.2Mnone on filenone on filenone on file
Shares outstanding58.5M55.0M60.3M85.8M87.5M